U.S. High Growth Tech and AI Stocks

Zscaler

Market Cap: US$38.0b

Operates as a cloud security company worldwide.

ACADIA Pharmaceuticals

Market Cap: US$2.9b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Gorilla Technology Group

Market Cap: US$333.8m

Provides solutions in security, network, business intelligence, and Internet of Things (IoT) technology in Taiwan and the United Kingdom.

Nutanix

Market Cap: US$21.5b

Provides an enterprise cloud platform in North America, Europe, the Asia Pacific, the Middle East, Latin America, and Africa.

Citius Oncology

Market Cap: US$63.3m

Focuses on the development of novel targeted oncology therapies.

Wix.com

Market Cap: US$10.2b

Operates a cloud-based web development platform for registered users and creators worldwide.

Elastic

Market Cap: US$9.6b

A search artificial intelligence (AI) company, delivers hosted and managed solutions designed to run in hybrid, public or private clouds, and multi-cloud environments in the United States and internationally.

CollPlant Biotechnologies

Market Cap: US$18.9m

A regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally.

aTyr Pharma

Market Cap: US$267.0m

A clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.

Arcutis Biotherapeutics

Market Cap: US$1.6b

A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

Precigen

Market Cap: US$386.7m

A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.

Cellebrite DI

Market Cap: US$4.1b

Develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.

HubSpot

Market Cap: US$35.0b

Provides a cloud-based customer relationship management (CRM) platform for businesses in the Americas, Europe, and the Asia Pacific.

Sea

Market Cap: US$97.5b

Through its subsidiaries, operates as a consumer internet company in Southeast Asia, Latin America, the rest of Asia, and internationally.

Atlassian

Market Cap: US$58.0b

Through its subsidiaries, designs, develops, licenses, and maintains various software products worldwide.

CrowdStrike Holdings

Market Cap: US$107.6b

Provides cybersecurity solutions in the United States and internationally.

Humacyte

Market Cap: US$347.5m

Engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas.

SoundHound AI

Market Cap: US$4.4b

Develops independent voice artificial intelligence (AI) solutions that enables businesses across automotive, TV, and IoT, and to customer service industries to deliver high-quality conversational experiences to their customers in the United States, Korea, France, Japan, Germany, and internationally.

BioCryst Pharmaceuticals

Market Cap: US$2.1b

A biotechnology company, develops oral small-molecule and injectable protein therapeutics to treat rare diseases.

TuHURA Biosciences

Market Cap: US$167.7m

A clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies.

Siyata Mobile

Market Cap: US$4.0m

Engages in the development and sale of vehicle-mounted, cellular-based communications platforms, and cellular booster systems in the United States, Canada, Europe, Australia, the Middle East, and internationally.

Ocugen

Market Cap: US$207.1m

A biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients’ health.

XOMA Royalty

Market Cap: US$321.9m

Operates as a biotech royalty aggregator in the United States and the Asia Pacific.

Unity Biotechnology

Market Cap: US$13.1m

A biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging.

AppLovin

Market Cap: US$124.1b

Engages in building a software-based platform for advertisers to enhance the marketing and monetization of their content in the United States and internationally.

Reddit

Market Cap: US$21.0b

Operates a digital community in the United States and internationally.

Invivyd

Market Cap: US$93.2m

A biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States.

Hut 8

Market Cap: US$1.6b

Operates as a vertically integrated operator of energy infrastructure and Bitcoin miners in North America.

Quoin Pharmaceuticals

Market Cap: US$4.5m

A late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.

Cheetah Mobile

Market Cap: US$119.4m

Cheetah Mobile Inc. along with its subsidiaries, engages in the provision of internet services, artificial intelligence (AI), and other services in the People’s Republic of China, Hong Kong, Japan, and internationally.

TriSalus Life Sciences

Market Cap: US$164.9m

Engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics for improving outcomes for patients with difficult-to-treat liver and pancreatic cancers.

BioRestorative Therapies

Market Cap: US$12.5m

Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.

BridgeBio Pharma

Market Cap: US$6.4b

A commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.

Q2 Holdings

Market Cap: US$5.6b

Provides digital solutions to financial institutions, financial technology companies, FinTechs, and alternative finance companies (Alt-FIs) in the United States.

BeiGene

Market Cap: US$24.4b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Vericel

Market Cap: US$2.1b

A commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America.